# Clinical Monitoring Strategy Versus Electrophysiology-guided Algorithmic Approach With a New LBBB After TAVI

Study · id `cardio:ct-nct03303612` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03303612](<https://clinicaltrials.gov/study/NCT03303612>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03303612

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 250 participants.

## Technical summary

Registry record NCT03303612. Randomized; no masking; primary purpose treatment. Start 2017-10-15 (actual); primary completion 2027-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 250 participants (planned count; ClinicalTrials.gov record NCT03303612, source copy `cardio:ctgov-nct03303612-2026-10-14`, retrieved 2026-10-26)
- Started: 2017-10-15 (actual) (ClinicalTrials.gov record NCT03303612, source copy `cardio:ctgov-nct03303612-2026-10-14`, retrieved 2026-10-26)
- Primary completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT03303612, source copy `cardio:ctgov-nct03303612-2026-10-14`, retrieved 2026-10-26)
- Completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT03303612, source copy `cardio:ctgov-nct03303612-2026-10-14`, retrieved 2026-10-26)
- Countries: Canada; France (ClinicalTrials.gov record NCT03303612, source copy `cardio:ctgov-nct03303612-2026-10-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03303612-2026-10-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Monitoring Strategy Versus Electrophysiology-guided Algorithmic Approach With a New LBBB After TAVI
- Acronym: COME-TAVI
- Condition: Left Bundle-Branch Block
- Condition: Aortic Valve Stenosis
- Intervention (Device): Pacemaker implant
- Intervention (Device): Transcutaneous cardiac monitor
- Lead sponsor: Montreal Heart Institute
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Heart block (`cardio:heart-block`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Montreal Heart Institute (`cardio:org-montreal-heart-institute`)

## Provenance

Content hash: 1d60c5127350e3ee70b27ae4a5abad578feb7cbce04dded73fb0b3119b0f4fd6
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
